Sector ratings Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. Other stock markets 2026-07-03			5-day change	1st Jan Change
186.01 ^CHF	+0.40%		+9.05%	-

07-01	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
07-01	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Visibility	Consensus
LONZA GROUP AG	49.92B		AAA
REVOLUTION MEDICINES, INC.	40.23B	-	B	-	-
IQVIA HOLDINGS INC.	34.55B		AAA
BEONE MEDICINES AG	33.09B		-
CELLTRION, INC.	27.51B		A
ASCENDIS PHARMA A/S	17.05B	-	-	-	-
MEDPACE HOLDINGS, INC.	15.92B		BBB
EUROFINS SCIENTIFIC SE	13.86B		AA
IONIS PHARMACEUTICALS, INC.	13.52B	-	A	-	-
ICON PUBLIC LIMITED COMPANY	13.26B		AAA
ABIVAX	13.31B	-	BBB	-	-
BIO-TECHNE CORPORATION	11.04B		AA
TEMPUS AI, INC.	10.82B		A		-
APOGEE THERAPEUTICS, INC.	9.96B	-	B	-	-
KYMERA THERAPEUTICS, INC.	9.34B	-	BBB	-	-
ALKERMES PLC	9.1B		A
PRAXIS PRECISION MEDICINES, INC.	8.88B	-	B	-	-
PROTAGONIST THERAPEUTICS, INC.	8.46B		BB		-
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-	-	-	-
Average	18.33B		A
Weighted average by Cap.			A